Search Results 981-990 of 13333 for monoclonal antibody

  1. Consultations - Antibody Hybridoma Core - Mayo Clinic Research

    Strategies for immunization and antibody screening and production. Type, form and amount of antigen(s) to be used. Timetable for immunization, fusion and ...

  2. Mayo Clinic Q&A podcast: COVID-19 variants and the evolving science

    Learn more about tracking COVID-19 and COVID-19 trends. Feb. 18, 2021- Mayo Clinic COVID-19 trending map using red color · Monoclonal antibody treatment helps ...

  3. A Study To Assess Monoclonal B-cell Lymphocytosis In Individuals With Chronic Hepatitis C - Mayo Clinic

    To assess the proportion of individuals with MBL who have an improvement in the circulating monoclonal B-cell population following therapy with DAA ...

  4. Brain Tumor Surgery Clinical Trials - Mayo Clinic Research

    Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

  5. To Compare The Effects Of Immediate-release Tacrolimus And Astagraf XL On Donor-Specific Antibody (DSA) Formation And The Development Of Immune Activation (IA) In De Novo Kidney Transplant Recipients - Mayo Clinic

    To Compare The Effects Of Immediate-release Tacrolimus And Astagraf XL On Donor-Specific Antibody ... monoclonal antibody, or Interleukin-2 (IL-2) co ...

  6. Untitled

    we have or monoclonal antibodies? ... Halena Gazelka 10:23. Greg, is it known yet if that antiviral would be used in conjunction with monoclonal antibody, for ...

  7. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time - Mayo Clinic

    The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myleoma (MM) ...

  8. An Extension Protocol For Multiple Sclerosis Patients Who Participated In Genzyme-Sponsored Studies Of Alemtuzumab - Mayo Clinic

    The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We ...

  9. Amyloidosis - Doctors and departments - Mayo Clinic

    Hematologist. Rochester, MN. Areas of focus: Bone marrow transplant, CAR-T cell therapy, Bispecific antibody therapy, Amyloidosis, Multiple myeloma, Waldenstrom ...

  10. Amyloidosis - Doctors and departments - Mayo Clinic

    Hematologist. Rochester, MN. Areas of focus: Bone marrow transplant, CAR-T cell therapy, Bispecific antibody therapy, Amyloidosis, Multiple myeloma, Waldenstrom ...